Provided by Tiger Trade Technology Pte. Ltd.

ORUKA THERAPEUTICS INC

107.96
+3.102.96%
Post-market: 106.82-1.1400-1.06%19:30 EDT
Volume:935.78K
Turnover:100.83M
Market Cap:7.15B
PE:-53.34
High:109.52
Open:105.48
Low:103.86
Close:104.86
52wk High:115.52
52wk Low:14.34
Shares:66.21M
Float Shares:56.65M
Volume Ratio:1.11
T/O Rate:1.65%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.0242
EPS(LYR):-1.8483
ROE:-18.23%
ROA:-12.95%
PB:6.43
PE(LYR):-58.41

Loading ...

Company Profile

Company Name:
ORUKA THERAPEUTICS INC
Exchange:
NASDAQ
Establishment Date:
- -
Employees:
- -
Office Location:
855 Oak Grove Avenue,Suite 100,Menlo Park,California,United States
Zip Code:
94025
Fax:
- -
Introduction:
ARCA biopharma, Inc., a clinical development stage biopharmaceutical company, engages in the development and commercialization of genetically targeted therapies for cardiovascular diseases. Its lead product candidate is Gencaro, a pharmacogenetically-targeted beta-adrenergic receptor antagonist that has completed Phase IIb trial for the treatment of atrial fibrillation in patients with chronic heart failure. It is also developing Recombinant Nematode Anticoagulant Protein c2 (rNAPc2) (AB201), a protein therapeutic that is in Phase IIb clinical trial for the treatment for COVID-19. ARCA biopharma, Inc. has a collaboration agreement with LabCorp to develop genetic test for GENETIC-AF clinical trial. The company was founded in 2004 and is headquartered in Westminster, Colorado.

Directors

Name
Position
Lawrence Otto Klein
Director, President and Chief Executive Officer
Samarth Kulkarni
Chairman
Carl Dambkowski
Independent Director
Christopher Martin
Independent Director
Kristine M. Ball
Independent Director
Peter Harwin
Independent Director

Shareholders

Name
Position
Lawrence Otto Klein
Director, President and Chief Executive Officer
Laura Sandler
Chief Operating Officer
Arjun Agarwal
Senior Vice President, Finance and Treasurer
Joana Goncalves
Chief Medical Officer
Paul T. Quinlan
General Counsel and Corporate Secretary